129 related articles for article (PubMed ID: 14519643)
21. Alteration of RPL14 in squamous cell carcinomas and preneoplastic lesions of the esophagus.
Huang XP; Zhao CX; Li QJ; Cai Y; Liu FX; Hu H; Xu X; Han YL; Wu M; Zhan QM; Wang MR
Gene; 2006 Jan; 366(1):161-8. PubMed ID: 16316724
[TBL] [Abstract][Full Text] [Related]
22. Microsatellite analysis of the APC gene and immunoexpression of E-cadherin, catenin, and tubulin in esophageal squamous cell carcinoma.
Nair KS; Naidoo R; Chetty R
Hum Pathol; 2006 Feb; 37(2):125-34. PubMed ID: 16426911
[TBL] [Abstract][Full Text] [Related]
23. Expression and prognostic value of MG7-Ag in patients with surgically resectable esophageal squamous cell carcinoma.
Zhao Y; Jiang Y; Wang R; Zheng X; Wang X; Jin B; Lu Y; Qiao T; Hong L; Fan D
Ann Surg Oncol; 2007 Sep; 14(9):2621-7. PubMed ID: 17570016
[TBL] [Abstract][Full Text] [Related]
24. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Sato T; Sugiyama A; Miyagawa S
Am J Gastroenterol; 2004 Sep; 99(9):1667-74. PubMed ID: 15330899
[TBL] [Abstract][Full Text] [Related]
25. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
[TBL] [Abstract][Full Text] [Related]
26. Frequent loss of heterozygosity on chromosome 10p14-p15 in esophageal dysplasia and squamous cell carcinoma.
Shima H; Hiyama T; Tanaka S; Ito M; Kitadai Y; Yoshihara M; Arihiro K; Haruma K; Chayama K
Oncol Rep; 2004 Aug; 12(2):333-7. PubMed ID: 15254698
[TBL] [Abstract][Full Text] [Related]
27. Plasma DNA as a molecular marker for completeness of resection and recurrent disease in patients with esophageal cancer.
Banki F; Mason RJ; Oh D; Hagen JA; DeMeester SR; Lipham JC; Tanaka K; Danenberg KD; Yacoub WN; Danenberg PV; DeMeester TR
Arch Surg; 2007 Jun; 142(6):533-8; discussion 538-9. PubMed ID: 17576889
[TBL] [Abstract][Full Text] [Related]
28. Allelic loss on chromosome bands 13q11-q13 in esophageal squamous cell carcinoma.
Li G; Hu N; Goldstein AM; Tang ZZ; Roth MJ; Wang QH; Dawsey SM; Han XY; Ding T; Huang J; Giffen C; Taylor PR; Emmert-Buck MR
Genes Chromosomes Cancer; 2001 Aug; 31(4):390-7. PubMed ID: 11433530
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite instability and clinicopathological features in esophageal squamous cell cancer.
Matsumoto Y; Nagasaka T; Kambara T; Hoshizima N; Murakami J; Sasamoto H; Hosokawa M; Naomoto Y; Isozaki H; Shimizu K; Tanaka N; Matsubara N
Oncol Rep; 2007 Nov; 18(5):1123-7. PubMed ID: 17914562
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
[TBL] [Abstract][Full Text] [Related]
31. Tetranucleotide microsatellite instability in surgical margins for prediction of local recurrence of head and neck squamous cell carcinoma.
Temam S; Casiraghi O; Lahaye JB; Bosq J; Zhou X; Julieron M; Mamelle G; Lee JJ; Mao L; Luboinski B; Benard J; Janot F
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4022-8. PubMed ID: 15217934
[TBL] [Abstract][Full Text] [Related]
32. Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma.
Kaku H; Ito S; Ebara S; Ouchida M; Nasu Y; Tsushima T; Kumon H; Shimizu K
Urology; 2004 Jul; 64(1):176-81. PubMed ID: 15245966
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.
Taback B; Fujiwara Y; Wang HJ; Foshag LJ; Morton DL; Hoon DS
Cancer Res; 2001 Aug; 61(15):5723-6. PubMed ID: 11479206
[TBL] [Abstract][Full Text] [Related]
34. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients.
Sozzi G; Conte D; Mariani L; Lo Vullo S; Roz L; Lombardo C; Pierotti MA; Tavecchio L
Cancer Res; 2001 Jun; 61(12):4675-8. PubMed ID: 11406535
[TBL] [Abstract][Full Text] [Related]
35. Expression of p53R2 is related to prognosis in patients with esophageal squamous cell carcinoma.
Okumura H; Natsugoe S; Yokomakura N; Kita Y; Matsumoto M; Uchikado Y; Setoyama T; Owaki T; Ishigami S; Aikou T
Clin Cancer Res; 2006 Jun; 12(12):3740-5. PubMed ID: 16778101
[TBL] [Abstract][Full Text] [Related]
36. Similar patterns of loss of heterozygosity in serum of adenocarcinoma of the distal oesophagus and the cardia in early diagnosis.
Wachowiak R; Kaifi JT; Schurr PG; Merkert P; Yekebas E; Schwarzenbach H; Strate T; Sauter G; Izbicki JR
Anticancer Res; 2007; 27(1A):477-81. PubMed ID: 17352270
[TBL] [Abstract][Full Text] [Related]
37. [Analyzing the profile of chromosomal imbalances in esophageal atypical hyperplasia and early stage esophageal squamous cell carcinoma by 250K Snp Array].
Zhang X; Zhu ZH; Lin P; Yang H; Fu JH; Zhang LJ; Long H; Wen J; Huang XP; Fang Y; Rong TH
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2636-41. PubMed ID: 19080713
[TBL] [Abstract][Full Text] [Related]
38. Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis.
Pawlik TM; Gleisner AL; Bauer TW; Adams RB; Reddy SK; Clary BM; Martin RC; Scoggins CR; Tanabe KK; Michaelson JS; Kooby DA; Staley CA; Schulick RD; Vauthey JN; Abdalla EK; Curley SA; Choti MA; Elias D
Ann Surg Oncol; 2007 Oct; 14(10):2807-16. PubMed ID: 17551795
[TBL] [Abstract][Full Text] [Related]
39. Circulating tumor cells and aberrant methylation as tumor markers in patients with esophageal cancer.
Ikoma D; Ichikawa D; Ueda Y; Tani N; Tomita H; Sai S; Kikuchi S; Fujiwara H; Otsuji E; Yamagishi H
Anticancer Res; 2007; 27(1B):535-9. PubMed ID: 17348438
[TBL] [Abstract][Full Text] [Related]
40. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
Taback B; Giuliano AE; Hansen NM; Singer FR; Shu S; Hoon DS
Cancer Res; 2003 Apr; 63(8):1884-7. PubMed ID: 12702578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
